IDEXX announces new test for H3N2 canine influenza
As veterinarians manage the H3N2 canine influenza outbreak spreading through the Chicago dog population and across the country, IDEXX Laboratories has released a new test for the detection of H3N2.
First identified in Asia in 2006, the H3N2 strain surfaced in the U.S. recently. IDEXX reports that it immediately began research and development and within four weeks had produced and validated a test. The result was the H3N2 Influenza Virus RealPCR Test, which allows for rapid, specific testing for the strain. IDEXX has added the new test to existing IDEXX Comprehensive Canine Respiratory Disease (CRD) RealPCR panels at no additional cost to customers. It also can be purchased as a standalone test.
“We have developed an accurate diagnostic for this canine influenza strain to ensure that veterinary practices across the country are equipped with the tools they need to provide the best possible care to their patients and to help contain this outbreak and keep it from spreading further in the United States,” says Christian Leutenegger, DVM, PhD, head of PCR molecular diagnostics at IDEXX Reference Laboratories, in a release.
For more information on the H3N2 test, go to idexx.com/canineh3n2.